---
title: "Huadong Medicine's Two Drugs Placed in China's Insurance Drug List"
type: "News"
locale: "zh-HK"
url: "https://longbridge.com/zh-HK/news/268897142.md"
description: "Huadong Medicine's Two Drugs Placed in China's Insurance Drug List"
datetime: "2025-12-08T04:30:51.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/268897142.md)
  - [en](https://longbridge.com/en/news/268897142.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/268897142.md)
---

> 支持的語言: [简体中文](https://longbridge.com/zh-CN/news/268897142.md) | [English](https://longbridge.com/en/news/268897142.md)


# Huadong Medicine's Two Drugs Placed in China's Insurance Drug List



### 相關股票

- [HUADONG MEDICINE (000963.CN)](https://longbridge.com/zh-HK/quote/000963.CN.md)

## 相關資訊與研究

- [Huadong Medicine's Unit Gets Nod for Hypertriglyceridemia Drug Clinical Trial](https://longbridge.com/zh-HK/news/274912733.md)
- [Huadong Medicine Gets U.S. Regulatory Nod for Liver Disease Drug Trial](https://longbridge.com/zh-HK/news/272634618.md)
- [InSilico Out-licensed Drug ISM4808 Begins Clinical Trial](https://longbridge.com/zh-HK/news/278010381.md)
- [Hutchmed to Withdraw Cancer Drug in China](https://longbridge.com/zh-HK/news/278378041.md)
- [Genedrive shareholders back fundraising as company expands pharmacogenetic footprint](https://longbridge.com/zh-HK/news/278383713.md)